000			02021 a2200505 4500
005			20250517020350.0
264		0	_c20160421
008			201604s 0 0 eng d
022			_a1569-8041
024	7		_a10.1093/annonc/mdv102 _2doi
040			_aNLM _beng _cNLM
100	1		_aWitzig, T E
245	0	0	_aA comprehensive review of lenalidomide therapy for B-cell non-Hodgkin lymphoma. _h[electronic resource]
260			_bAnnals of oncology : official journal of the European Society for Medical Oncology _cAug 2015
300			_a1667-77 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650	0	4	_aAntibodies, Monoclonal, Murine-Derived _xtherapeutic use
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBendamustine Hydrochloride _xadministration & dosage
650	0	4	_aCyclophosphamide _xtherapeutic use
650	0	4	_aDoxorubicin _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aImmunologic Factors _xtherapeutic use
650	0	4	_aLenalidomide
650	0	4	_aLymphoma, B-Cell _xdrug therapy
650	0	4	_aLymphoma, Follicular _xdrug therapy
650	0	4	_aLymphoma, Large B-Cell, Diffuse _xdrug therapy
650	0	4	_aLymphoma, Mantle-Cell _xdrug therapy
650	0	4	_aLymphoma, Non-Hodgkin _xdrug therapy
650	0	4	_aPrednisone _xtherapeutic use
650	0	4	_aRituximab _xadministration & dosage
650	0	4	_aThalidomide _xadministration & dosage
650	0	4	_aTreatment Outcome
650	0	4	_aVincristine _xtherapeutic use
700	1		_aNowakowski, G S
700	1		_aHabermann, T M
700	1		_aGoy, A
700	1		_aHernandez-Ilizaliturri, F J
700	1		_aChiappella, A
700	1		_aVitolo, U
700	1		_aFowler, N
700	1		_aCzuczman, M S
773	0		_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 26 _gno. 8 _gp. 1667-77
856	4	0	_uhttps://doi.org/10.1093/annonc/mdv102 _zAvailable from publisher's website
999			_c24652890 _d24652890